HXL vs ZBH · P/E 59, rev $529.3M vs P/E 23, rev $8.23B
Hexcel Corporation (HXL) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Hexcel Corporation (HXL) is a aerospace & defense company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported HXL revenue for 2026-06-30 was $529.3M. Net income was $49.3M. Revenue was up 5.5% from 2026-03-31 to 2026-06-30. HXL currently screens at market cap $6.73B and trailing P/E 59.0.
Latest reported ZBH revenue for 2025-12-31 was $8.23B. Net income was $705.1M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
HXL currently screens at market cap $6.73B and trailing P/E 59.0. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the HXL and ZBH stock pages for the full models.
Not investment advice.